期刊
BRAIN RESEARCH
卷 1677, 期 -, 页码 93-100出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.brainres.2017.09.026
关键词
Epileptiform-like discharges; A beta plaques; EEG; Pentylenetetrazole; DSP4
资金
- Ministerio de Economia y Competitividad [SAF2016-76462 AEI/FEDER]
Alzheimer's disease is a common age associated neurodegenerative disorder associated with an elevated risk of seizures that may be fundamentally connected to cognitive dysfunction. We used 4-9 month-old mice of the APP/PS1 mouse model of Alzheimer's disease to study the presence of epileptiform-like discharges and to establish if the amyloid-beta plaques affect their generation. The EEG of the APP/PS1 trans genic mice revealed a higher incidence of epileptiform-like discharges i.e. seizure events (interictal spikes, sharp waves, or polyspikes) than in the controls. Also, APP/PS1 mice showed a lower latency to evoke seizure events than in the control animals when pentylenetetrazole (60 mg/kg; i.p.) was injected. Moreover, physostigmine injection (1 mg/kg; i.p.) also increased the frequency of spontaneous epileptiform-like discharges in the APP/PS1 mice. We also found a correlation between the frequency of epileptiform-like discharges and the number of amyloid-beta plaques. Application of N-(2-chloroethyl)-N-ethyl-bromobenzylamine (50 mg/kg) generated amyloid-beta plaques in the cortex and seizure activity appeared. Taken together, these data indicate that deposits of amyloid-beta plaques may be responsible for the epileptiform-like discharges recorded in the APP/PS1 mice and could be responsible for the elevated risk for seizures of Alzheimer's patients. (C) 2017 Published by Elsevier B.V.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据